In addition, studies from our laboratory and others have demonstrated that the levels of circulating CHI3L1 are also increased in the very diseases that are COVID-19 risk factors (52–59), where they correlate with disease severity (54, 55, 58). Here, CHI3L1 is linked to COVID-19.